Alexion Pharma Poland Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Secondary Activities: Accounting, Tax Preparation, Bookkeeping, and Payroll Services | Administrative Management and General Management Consulting Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Advertising, Public Relations, and Related Services | Advertising Agencies | Convention and Trade Show Organizers | All Other Support Services

Full name: Alexion Pharma Poland Sp. z o.o.

Profile Updated: April 26, 2025

Alexion Pharma Poland Sp. z o.o. is a company in Poland, with a head office in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. Alexion Pharma Poland Sp. z o.o. was incorporated on March 17, 2022. Its total assets grew by 13558.58% over the same period.

Headquarters
Ul. Postepu 14
Warsaw; Mazowieckie; Postal Code: 02-676

Contact Details: Purchase the Alexion Pharma Poland Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Alexion Pharma Poland Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Alexion Pharma Poland Sp. z o.o. report to view the information.

Incorporation Date:

March 17, 2022

Key Executives

Purchase this report to view the information.

Management Board Member

Purchase this report to view the information.

Management Board Member

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Alexion Pharma Poland Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Operating profit (EBIT)

N/A

EBITDA

N/A

Net Profit (Loss) for the Period

N/A

Total Assets

13558.58%▲

Total Equity

N/A

Return on Equity (ROE)

26.86%▲